| An intranasal administration of Lactococcus lactis strains expressing recombinant interleukin-10 modulates acute allergic airway inflammation in a murine model. | |
| | |
MedLine Citation:
|
PMID: 20412136 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Around 300 million people world-wide suffer from asthma, and the prevalence of allergic diseases has increased. Much effort has been used in the study of mechanisms involved in the immune response observed in asthma to intervene for the treatment of this condition. During inflammation in asthma, Th2 cytokines and eosinophils are essential components of the host immune system. Furthermore, for therapeutic interventions against this disease, IL-10 is an important cytokine because it has a central role in the regulation of inflammatory cascades. OBJECTIVE: To evaluate the immunomodulatory effect of Lactococcus lactis strains expressing recombinant IL-10 in a mouse model of ovalbumin (OVA)-induced acute airway inflammation. METHODS: L. lactis expressing recombinant IL-10 in a cytoplasmic (LL-CYT) or secreted form (LL-SEC) and wild-type (LL-WT) were used. IL-10 production by the recombinant strains was evaluated by ELISA. After an intranasal administration of L. lactis producing recombinant IL-10 and the induction of acute allergic airway inflammation in mice, blood samples were collected to detect IgE anti-OVA, and bronchoalveolar lavage (BAL) was harvested for eosinophil count. Additionally, the lungs were collected for the detection of the eosinophil peroxidase (EPO) activity, measurement of cytokines and chemokines and evaluation of pathology. RESULTS: Mice that received LL-CYT and LL-SEC strains showed a significant decrease in eosinophils numbers, EPO activity, anti-OVA IgE and IgG1 levels, IL-4 and CCL3 production and pulmonary inflammation and mucus hypersecretion, compared with the asthmatic group. Only the LL-CYT/OVA group showed reduced levels of IL-5, CCL2, CCL5 and CCL11. CONCLUSION: Treatment with L. lactis producing recombinant IL-10 used in this study (LL-CYT and LL-SEC) modulated experimental airway inflammation in the mouse model independently of Treg cells. Additionally, the LL-CYT strain was more efficient in the suppression of lung inflammation. |
| | |
Authors:
|
F A V Marinho; L G G Pacífico; A Miyoshi; V Azevedo; Y Le Loir; V D Guimarães; P Langella; G D Cassali; C T Fonseca; S C Oliveira |
Related Documents
:
|
12568486 - Post-secretory fate of host defence components in mucus. 19109196 - Cd11b+ myeloid cells are the key mediators of th2 cell homing into the airway in allerg... 17632526 - Extracellular atp triggers and maintains asthmatic airway inflammation by activating de... 2701476 - Drug-mucus actions and interactions. 8835196 - Substance p modulates human immunodeficiency virus replication in human peripheral bloo... 17352226 - Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induc... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology Volume: 40 ISSN: 1365-2222 ISO Abbreviation: Clin. Exp. Allergy Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-12 Completed Date: 2011-01-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8906443 Medline TA: Clin Exp Allergy Country: England |
Other Details:
|
Languages: eng Pagination: 1541-51 Citation Subset: IM |
Copyright Information:
|
© 2010 Blackwell Publishing Ltd. |
Affiliation:
|
Department of Biochemistry and Immunology, Biological Sciences Institute, Federal University of Minas Gerais Minas Gerais, Belo Horizonte, MG, Brazil. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Intranasal Animals Asthma / immunology, pathology Cell Separation Cytokines / analysis, immunology Disease Models, Animal Enzyme-Linked Immunosorbent Assay Female Flow Cytometry Gene Therapy / methods* Genetic Vectors Hypersensitivity / immunology*, pathology Immunoglobulin E / blood, immunology Immunoglobulin G / blood, immunology Immunotherapy / methods Interleukin-10 / biosynthesis*, genetics, immunology Lactococcus lactis / genetics* Lung / immunology, pathology Mice Mice, Inbred BALB C Ovalbumin / immunology Pneumonia / immunology*, pathology Recombinant Proteins / immunology Th2 Cells / immunology |
| Chemical | |
Reg. No./Substance:
|
0/Cytokines; 0/Immunoglobulin G; 0/Recombinant Proteins; 130068-27-8/Interleukin-10; 37341-29-0/Immunoglobulin E; 9006-59-1/Ovalbumin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine ex...
Next Document: Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflam...